289 related articles for article (PubMed ID: 16794490)
21. [Clinical and vascular effects of ACE inhibitor enalapril in combination with thiaside-like diuretic indapamide in hypertensive outpatients. Results of the multicenter trial POEMA].
Belenkov IuN; Ageev FT; Orolova IaA; Abrosimova OIu; Volkova EG; Gapon LI; Katel'nitskaia LI; Kondari AO; Patrusheva IF; Fomin IV; Khokhlov RA
Ter Arkh; 2007; 79(8):33-8. PubMed ID: 17926468
[TBL] [Abstract][Full Text] [Related]
22. Integrated effects of the vasodilating beta-blocker nebivolol on exercise performance, energy metabolism, cardiovascular and neurohormonal parameters in physically active patients with arterial hypertension.
Predel HG; Mainka W; Schillings W; Knigge H; Montiel J; Fallois J; Agrawal R; Schramm T; Graf C; Giannetti BM; Bjarnason-Wehrens B; Prinz U; Rost RE
J Hum Hypertens; 2001 Oct; 15(10):715-21. PubMed ID: 11607802
[TBL] [Abstract][Full Text] [Related]
23. Haemorheological disturbances in hypertensive type 2 diabetic patients--influence of antihypertensive therapy.
Kearney-Schwartz A; Virion JM; Stoltz JF; Drouin P; Zannad F
Fundam Clin Pharmacol; 2007 Aug; 21(4):387-96. PubMed ID: 17635177
[TBL] [Abstract][Full Text] [Related]
24. Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life.
Van Bortel LM; Breed JG; Joosten J; Kragten JA; Lustermans FA; Mooij JM
J Cardiovasc Pharmacol; 1993 Jun; 21(6):856-62. PubMed ID: 7687708
[TBL] [Abstract][Full Text] [Related]
25. Effects of the systemic beta-adrenoceptor antagonist nebivolol on ocular hemodynamics in glaucoma patients.
Zeitz O; Galambos P; Matthiesen N; Wagenfeld L; Schillinger W; Wiermann A; Richard G; Klemm M
Med Sci Monit; 2008 May; 14(5):CR268-275. PubMed ID: 18443551
[TBL] [Abstract][Full Text] [Related]
26. Does nebivolol improve endothelial dysfunction and will it rescue the reputation of the beta-blockers in the future?
Celik T; Iyisoy A
Anadolu Kardiyol Derg; 2007 Dec; 7(4):388-9. PubMed ID: 18065334
[No Abstract] [Full Text] [Related]
27. Effects of nebivolol or irbesartan in combination with hydrochlorothiazide on vascular functions in newly-diagnosed hypertensive patients: the NINFE (Nebivololo, Irbesartan Nella Funzione Endoteliale) study.
Vitale C; Marazzi G; Iellamo F; Spoletini I; Dall'Armi V; Fini M; Volterrani M
Int J Cardiol; 2012 Mar; 155(2):279-84. PubMed ID: 22078979
[TBL] [Abstract][Full Text] [Related]
28. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
[TBL] [Abstract][Full Text] [Related]
29. [Urinary albumin excretion in non-insulin-dependent diabetic patients. Effects of an angiotensin-converting enzyme inhibitor].
Durruty P; Tapia JC; Ugarte C; Pérez E; Krause P; Soto N; García de los Ríos M
Rev Med Chil; 1996 Sep; 124(9):1036-44. PubMed ID: 9197016
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patients with essential hypertension.
Tuncer M; Guntekin U; Gunes Y; Gumrukcuoglu HA; Eryonucu B
Adv Ther; 2008 Jun; 25(6):619-26. PubMed ID: 18563311
[TBL] [Abstract][Full Text] [Related]
31. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
[TBL] [Abstract][Full Text] [Related]
32. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethlyarginine levels in hypertensive patients with type 2 diabetes mellitus.
Menevşe E
Anadolu Kardiyol Derg; 2008 Feb; 8(1):84; author reply 84. PubMed ID: 18258550
[No Abstract] [Full Text] [Related]
33. Enhancement of blood glucose lowering effect of a sulfonylurea when coadministered with an ACE inhibitor: results of a glucose-clamp study.
Rave K; Flesch S; Kühn-Velten WN; Hompesch BC; Heinemann L; Heise T
Diabetes Metab Res Rev; 2005; 21(5):459-64. PubMed ID: 15915547
[TBL] [Abstract][Full Text] [Related]
34. Impact of nebivolol on levels of serum nitric oxide, plasma von Willebrand factor and exercise stress testing parameters in hypertensive and ischemic heart disease patients.
Kobusiak-Prokopowicz M; Jołda-Mydłowska B; Zubkiewicz A; Szymczak M; Mysiak A; Skalik R
Cardiol J; 2008; 15(2):162-8. PubMed ID: 18651401
[TBL] [Abstract][Full Text] [Related]
35. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection.
Mahmud A; Feely J
Am J Hypertens; 2008 Jun; 21(6):663-7. PubMed ID: 18437130
[TBL] [Abstract][Full Text] [Related]
36. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
Flather MD; Shibata MC; Coats AJ; Van Veldhuisen DJ; Parkhomenko A; Borbola J; Cohen-Solal A; Dumitrascu D; Ferrari R; Lechat P; Soler-Soler J; Tavazzi L; Spinarova L; Toman J; Böhm M; Anker SD; Thompson SG; Poole-Wilson PA;
Eur Heart J; 2005 Feb; 26(3):215-25. PubMed ID: 15642700
[TBL] [Abstract][Full Text] [Related]
37. [Clinical efficacy of combined therapy with enalapril + trimetazidine in patients with hypertension comorbid with ischemic heart disease and metabolic disturbances].
Petelina TI; Gapon LI; Bakhmatova IuA; Zhevagina IA
Ter Arkh; 2005; 77(8):19-23. PubMed ID: 16206600
[TBL] [Abstract][Full Text] [Related]
38. EVOLVE (nebivolol evaluation for efficacy and safety in the treatment of hypertension) postmarketing surveillance study.
Faruqui AA
J Indian Med Assoc; 2007 May; 105(5):272, 274, 276-7. PubMed ID: 17915798
[TBL] [Abstract][Full Text] [Related]
39. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[TBL] [Abstract][Full Text] [Related]
40. [Clinical and metabolic effects of cardioselective beta-adrenoblockers nebivolol and metoprolol in patients with hypertension and ischemic heart disease associated with type 2 diabetes].
Makolkin VI; Akhmedova OO; Buval'tsev VI; Gavrilov IuV; Petriĭ VV
Kardiologiia; 2003; 43(2):40-3. PubMed ID: 12891271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
